Interestingly, this study also found that in colon cancer xenografts, ZBTB7A represses the expression of genes in the glycolytic pathway, a metabolic pathway that is required for aggressive tumour growth, and that inhibition of this pathway reduces tumour growth. Here, ZBTB7A is linked to colonic neoplasm.